Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Lessons learned from Vietnam’s COVID-19 response: the role of adaptive behavior change and testing in epidemic control

Quang D. Pham, Robyn M. Stuart, Thuong V. Nguyen, Quang C. Luong, Dai Q. Tran, Thai Q. Pham, Lan T. Phan, Tan Q. Dang, Duong N. Tran, Hung T. Do, Dina Mistry, Daniel J. Klein, Romesh G. Abeysuriya, Assaf P. Oron, Cliff C. Kerr
doi: https://doi.org/10.1101/2020.12.18.20248454
Quang D. Pham
1Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robyn M. Stuart
2Department of Mathematical Sciences, University of Copenhagen, Copenhagen, Denmark
3Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robyn@math.ku.dk
Thuong V. Nguyen
1Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quang C. Luong
1Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dai Q. Tran
4General Department of Preventive Medicine, Hanoi, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thai Q. Pham
5National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
6School of Preventive Medicine and Public Health, Hanoi University, Hanoi, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan T. Phan
1Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tan Q. Dang
4General Department of Preventive Medicine, Hanoi, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duong N. Tran
5National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hung T. Do
7Pasteur Institute of Nha Trang, Nha Trang, Vietnam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dina Mistry
8Institute for Disease Modeling at the Bill & Melinda Gates Foundation, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Klein
8Institute for Disease Modeling at the Bill & Melinda Gates Foundation, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Romesh G. Abeysuriya
3Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Assaf P. Oron
8Institute for Disease Modeling at the Bill & Melinda Gates Foundation, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cliff C. Kerr
8Institute for Disease Modeling at the Bill & Melinda Gates Foundation, Seattle, USA
9School of Physics, University of Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Vietnam has emerged as one of the world’s leading success stories in responding to COVID-19. After prolonged zero-low transmission, a summer outbreak of unknown source at Da Nang caused the country’s first COVID-19 deaths, but was quickly suppressed. Vietnam recently reopened its borders to international travelers. Understanding the attendant risks and how to minimize them is crucial as Vietnam moves into this new phase.

Methods We create an agent-based model of COVID-19 in Vietnam, using regional testing data and a detailed linelist of the 1,014 COVID-19 cases, including 35 deaths, identified across Vietnam. We investigate the Da Nang outbreak, and quantify the risk of another outbreak under different assumptions about behavioral/policy responses and ongoing testing.

Results The Da Nang outbreak, although rapidly contained once detected, nevertheless caused significant community transmission before it was detected; higher symptomatic testing could have mitigated this. If testing levels do not increase, the adoption of past policies in response to newly-detected cases may reduce the size of potential outbreaks but will not prevent them. Compared to a baseline symptomatic testing rate of 10%, we estimate half as many infections under a 20% testing rate, and a quarter as many with 40-50% testing rates, over the four months following border reopenings.

Conclusions Vietnam’s success in controlling COVID-19 is largely attributable to its rapid response to detected outbreaks, but the speed of response could be improved even further with higher levels of symptomatic testing.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding was provided by Vietnam's Ministry of Science and Technology (Grant: 32/20-ĐTĐL.CN-CNN)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not required

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Code for Covasim is available from https://github.com/institutefordiseasemodeling/covasim. The code and data used to run all the analyses that are included in this article are available from the corresponding author upon request during the article review period, and will be placed in a public GitHub repository after manuscript acceptance.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 19, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Lessons learned from Vietnam’s COVID-19 response: the role of adaptive behavior change and testing in epidemic control
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lessons learned from Vietnam’s COVID-19 response: the role of adaptive behavior change and testing in epidemic control
Quang D. Pham, Robyn M. Stuart, Thuong V. Nguyen, Quang C. Luong, Dai Q. Tran, Thai Q. Pham, Lan T. Phan, Tan Q. Dang, Duong N. Tran, Hung T. Do, Dina Mistry, Daniel J. Klein, Romesh G. Abeysuriya, Assaf P. Oron, Cliff C. Kerr
medRxiv 2020.12.18.20248454; doi: https://doi.org/10.1101/2020.12.18.20248454
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Lessons learned from Vietnam’s COVID-19 response: the role of adaptive behavior change and testing in epidemic control
Quang D. Pham, Robyn M. Stuart, Thuong V. Nguyen, Quang C. Luong, Dai Q. Tran, Thai Q. Pham, Lan T. Phan, Tan Q. Dang, Duong N. Tran, Hung T. Do, Dina Mistry, Daniel J. Klein, Romesh G. Abeysuriya, Assaf P. Oron, Cliff C. Kerr
medRxiv 2020.12.18.20248454; doi: https://doi.org/10.1101/2020.12.18.20248454

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (860)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (250)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8562)
  • Forensic Medicine (4)
  • Gastroenterology (384)
  • Genetic and Genomic Medicine (1753)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1244)
  • Health Policy (621)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (374)
  • Infectious Diseases (except HIV/AIDS) (10303)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1678)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (253)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1770)
  • Public and Global Health (3841)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)